Press release from Companies: DanCann Pharma A/S publishes Q1-2023 report

Press release from Companies: DanCann Pharma A/S: MINUTES OF ANNUAL GENERAL MEETING

Press release from Companies: DanCann Pharma A/S has secured 71 percent of the TO 2’s

Press release from Companies: DanCann Pharma A/S has successfully completed pre-validation batches and expects final approval from the Danish Medicines Agency by the end of summer

Press release from Companies: DanCann Pharma A/S in advanced talks with new investor of additional DKK 12 million for topping up the outcome of the TO 2’s

Market Notices: Market Notice 110/23– Last day of trading in DanCann Pharma A/S´s subscription option DANCAN TO 2

Press release from Companies: Correction: DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants

Press release from Companies: DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants

Press release from Companies: DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today

Press release from Companies: DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set

Press release from Companies: DanCann Pharma A/S styrker sit regulatoriske fokus med indstilling af life science-advokat til bestyrelsen

Press release from Companies: DanCann Pharma A/S is strengthening its regulatory focus by appointing a life science lawyer to the board of directors